West Pharmaceutical Services Accounts Payable

West Pharmaceutical Services (WST) currently reports a accounts payable of $250M as of June 2026. That compares with $240M in the prior-year period — up 5.7% year over year. Use the charts on this page to explore West Pharmaceutical Services's accounts payable history and peer comparisons.

West Pharmaceutical Services's accounts payable increased from $240M to $250M — a 5.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

West Pharmaceutical Services reported $250M in accounts payable as of June 2026. That compares with $240M in the prior-year period — up 5.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $250M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for West Pharmaceutical Services, and consider following WST for alerts when major investors trade the stock.

West Pharmaceutical Services is classified in the Healthcare sector. On accounts payable, it currently shows $250M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing WST with unrelated industries.